Items where Author is "Loges, Sonja"
![]() | Up a level |
Article
Illini, Oliver and Saalfeld, Felix Carl and Christopoulos, Petros and Duruisseaux, Michael and Vikstroem, Anders and Peled, Nir and Demedts, Ingel and Dudnik, Elizabeth and Eisert, Anna and Hashemi, Sayed M. S. and Janzic, Urska and Kian, Waleed and Mohorcic, Katja and Mohammed, Saara and Silvoniemi, Maria and Rothschild, Sacha I. and Schulz, Christian and Wesseler, Claas and Addeo, Alfredo and Armster, Karin and Itchins, Malinda and Ivanovic, Marija and Kauffmann-Guerrero, Diego and Koivunen, Jussi and Kuon, Jonas and Pavlakis, Nick and Piet, Berber and Sebastian, Martin and Velthaus-Rusik, Janna-Lisa and Wannesson, Luciano and Wiesweg, Marcel and Wurm, Robert and Albers-Leischner, Corinna and Aust, Daniela E. and Janning, Melanie and Fabikan, Hannah and Herold, Sylvia and Klimova, Anna and Loges, Sonja and Sharapova, Yana and Schuetz, Maret and Weinlinger, Christoph and Valipour, Arschang and Overbeck, Tobias Raphael and Griesinger, Frank and Jakopovic, Marko and Hochmair, Maximilian J. and Wermke, Martin (2024) Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25 (7): 3992. ISSN 1661-6596, 1422-0067
Bischoff, Philip and Reck, Martin and Overbeck, Tobias and Christopoulos, Petros and Rittmeyer, Achim and Lueders, Heike and Kollmeier, Jens and Kulhavy, Jonas and Kemper, Marcel and Reinmuth, Niels and Roeper, Julia and Janning, Melanie and Sommer, Linna and Aguinarte, Lukas and Koch, Myriam and Wiesweg, Marcel and Wesseler, Claas and Waller, Cornelius F. and Kauffmann-Guerrero, Diego and Stenzinger, Albrecht and Stephan-Falkenau, Susann and Trautmann, Marcel and Lassmann, Silke and Tiemann, Markus and Klauschen, Frederick and Sebastian, Martin and Griesinger, Frank and Wolf, Juergen and Loges, Sonja and Frost, Nikolaj (2024) Outcome of First-Line Treatment With Pembrolizumab According to KRAS / TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 19 (5). pp. 803-817. ISSN 1556-0864, 1556-1380
Christopoulos, Petros and Kluck, Klaus and Kirchner, Martina and Lueders, Heike and Roeper, Julia and Falkenstern-Ge, Roger-Fei and Szewczyk, Marlen and Sticht, Florian and Saalfeld, Felix C. and Wesseler, Claas and Hackanson, Bjoern and Dintner, Sebastian and Faehling, Martin and Kuon, Jonas and Janning, Melanie and Kauffmann-Guerrero, Diego and Kazdal, Daniel and Kurz, Sylke and Eichhorn, Florian and Bozorgmehr, Farastuk and Shah, Rajiv and Tufman, Amanda and Wermke, Martin and Loges, Sonja and Brueckl, Wolfgang M. and Schulz, Christian and Misch, Daniel and Frost, Nikolaj and Kollmeier, Jens and Reck, Martin and Griesinger, Frank and Grohe, Christian and Hong, Jin-Liern and Lin, Huamao M. and Budczies, Jan and Stenzinger, Albrecht and Thomas, Michael (2022) The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. EUROPEAN JOURNAL OF CANCER, 170. pp. 106-118. ISSN 0959-8049, 1879-0852

